Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $801.4850 (-0.05%) ($794.5400 - $801.4850) on Mon. Nov. 20, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.13% (three month average) | RSI | 62 | Latest Price | $801.4850(-0.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.2% a day on average for past five trading days. | Weekly Trend | REGN declines -0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(46%) SPLV(40%) SDY(39%) XLV(38%) XLF(33%) | Factors Impacting REGN price | REGN will decline at least -0.565% in a week (0% probabilities). VXX(-27%) UNG(-27%) ONLN(-27%) USO(-26%) XLE(-20%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.565% (StdDev 1.13%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $797.07(0.55%) | 10 Day Moving Average | $802.72(-0.15%) | 20 Day Moving Average | $800.9(0.07%) | To recent high | -5.2% | To recent low | 3.4% | Market Cap | $84.98b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |